首页|Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight

Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight

扫码查看
原文链接
  • NETL
  • NSTL
  • 维普
  • 万方数据
Coronaviruses (CoVs) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS).Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has caused major public health crises.There have been more than 4,400,000 reported cases of COVID-2019 and more than 300,000 reported deaths to date (16/05/2020).SARS-CoV,MERS-CoV and SARS-CoV-2 have attracted widespread global attention due to their high infectivity and pathogenicity.To date,there is no specific treatment proven effective against these viral infectious diseases.Vaccination is considered one of the most effective strategies to prevent viral infections.Therefore,the development of effective vaccines against highly pathogenic coronaviruses is essential.In this review,we will briefly describe coronavirus vaccine design targets,summarize recent advances in the development of coronavirus vaccines,and highlight current adjuvants for improving the efficacy of coronavirus vaccines.

CoronavirusesSARS-CoVMERS-CoVSARS-CoV-2VaccineAdjuvant

Chunting He、Ming Qin、Xun Sun

展开 >

Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu 610041, China

We acknowledge the financial support of the National Natural Science Foundation of ChinaSpecial Funds for Prevention and Control of COVID-19 of Sichuan UniversitySpecial Funds for Prevention and Control of COVID-19 of Sichuan UniversityZhejiang University special scientific research fu

No81925036No0082604151018China

2020

药学学报(英文版)

药学学报(英文版)

CSTPCDCSCDSCI
ISSN：
年,卷(期)：2020.10(7)
  • 7
  • 2